Why the study?
Do biomarkers of endothelial function and fibrinolysis predict progression to pre-diabetes more strongly in women than men?
Do biomarkers of endothelial function and fibrinolysis predict progression to pre-diabetes more strongly in women than men?
Women who progress from normoglycemia to pre-diabetes exhibit significantly greater endothelial dysfunction and pro-thrombotic biomarker profiles compared to men, suggesting cardiovascular risk mechanisms may activate earlier in women.
Answers are grounded in this paper and cite their sources.
May indicate earlier endothelial risk activation in women; leaves open whether biomarkers enhance sex-specific pre-diabetes prediction.
OBJECTIVE—We examined whether biomarkers of endothelial function, fibrinolysis/thrombosis and adiponectin, predict the progression from normal to pre-diabetes more strongly among women than men over 6 years of follow-up from the Western New York Health Study. RESEARCH DESIGN AND METHODS—In 2002–2004, 1,455 participants from the Western New York Health Study, who were free of type 2 diabetes and cardiovascular disease at baseline (1996–2001), were selected for reexamination. An incident case of pre-diabetes was defined as fasting glucose <100 mg/dl at the baseline examination and ≥100 and <126 mg/dl at the follow-up examination. Biomarkers of endothelial function (E-selectin and soluble intracellular adhesion molecule-1 [sICAM-1]), fibrinolysis/thrombosis (plasminogen activator inhibitor-1 [PAI-1]), and fasting insulin, adiponectin, and inflammation (high-sensitivity C-reactive protein) were measured in frozen (−190°C) baseline samples. RESULTS—Multivariate analyses revealed higher adjusted mean values of biomarkers of endothelial dysfunction (E-selectin and sICAM-1) and fibrinolysis (PAI-1) and lower mean values of adiponectin only among women who developed pre-diabetes compared with control subjects. Formal tests for interaction between sex and case/control status were statistically significant for E-selectin (P = 0.042), PAI-1 (P = 0.001), sICAM-1 (P = 0.011), and frequency of hypertension (P < 0.001). CONCLUSIONS—These results support the concept that women who progressed from normoglycemia to pre-diabetes have greater endothelial dysfunction than men as well as more hypertension and a greater degree of fibrinolysis/thrombosis. Whether this relates to the higher risk of heart disease among diabetic women awaits further study.
No takes yet. Share an insight, caveat, or question.
Donahue et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: